OBJECTIVE: To investigate the incidence, implicating factors and outcome of acute kidney injury (AKI) after cardiopulmonary bypass (CPB) in patients admitted to a pediatric cardiothoracic intensive care unit (ICU). DESIGN: A retrospective review study. SETTING: A 10-bed cardiothoracic ICU. PATIENTS: One hundred and twenty-four children (<18 years of age) admitted to the cardiothoracic ICU following CPB between January 2007 and December 2009. METHODS: Age, sex, diagnosis, baseline and post-surgery hemoglobin, total leukocyte count, platelet count and biochemistry were recorded. Baseline and postoperative urea (mg/dl), creatinine (mg/dl), urine output (ml/kg/h) and inotrope dose were also recorded daily. The duration of CPB was noted. Postoperative cardiac, renal, hepatic, neurologic and respiratory dysfunctions were recorded. RESULTS: Seven (5%) children developed AKI stage I, five children (4%) developed AKI stage II and two children developed AKI stage III (2%). All patients with AKI had a longer stay in hospital and increased mortality. Two children required dialysis for AKI and none developed chronic renal impairment. All patients with AKI stage III died during the ICU stay. Using stepwise regression, younger age (<1 year), weight <10 kg, pump failure, sepsis and duration of CPB >90 min were significant risk factors identified for developing AKI. CONCLUSIONS: AKI is common and occurred in 11% of our patients following CPB; however, AKI requiring renal replacement therapy is uncommon.
OBJECTIVE: To investigate the incidence, implicating factors and outcome of acute kidney injury (AKI) after cardiopulmonary bypass (CPB) in patients admitted to a pediatric cardiothoracic intensive care unit (ICU). DESIGN: A retrospective review study. SETTING: A 10-bed cardiothoracic ICU. PATIENTS: One hundred and twenty-four children (<18 years of age) admitted to the cardiothoracic ICU following CPB between January 2007 and December 2009. METHODS: Age, sex, diagnosis, baseline and post-surgery hemoglobin, total leukocyte count, platelet count and biochemistry were recorded. Baseline and postoperative urea (mg/dl), creatinine (mg/dl), urine output (ml/kg/h) and inotrope dose were also recorded daily. The duration of CPB was noted. Postoperative cardiac, renal, hepatic, neurologic and respiratory dysfunctions were recorded. RESULTS: Seven (5%) children developed AKI stage I, five children (4%) developed AKI stage II and two children developed AKI stage III (2%). All patients with AKI had a longer stay in hospital and increased mortality. Two children required dialysis for AKI and none developed chronic renal impairment. All patients with AKI stage III died during the ICU stay. Using stepwise regression, younger age (<1 year), weight <10 kg, pump failure, sepsis and duration of CPB >90 min were significant risk factors identified for developing AKI. CONCLUSIONS: AKI is common and occurred in 11% of our patients following CPB; however, AKI requiring renal replacement therapy is uncommon.
Authors: S Dittrich; M Priesemann; T Fischer; W Boettcher; C Müller; I Dähnert; P Ewert; V Alexi-Meskishvili; R Hetzer; P E Lange Journal: Cardiol Young Date: 2001-09 Impact factor: 1.093
Authors: Timothy M Hoffman; Gil Wernovsky; Andrew M Atz; James M Bailey; Akbar Akbary; John F Kocsis; David P Nelson; Anthony C Chang; Thomas J Kulik; Thomas L Spray; David L Wessel Journal: Am Heart J Date: 2002-01 Impact factor: 4.749
Authors: Michael Bennett; Catherine L Dent; Qing Ma; Sudha Dastrala; Frank Grenier; Ryan Workman; Hina Syed; Salman Ali; Jonathan Barasch; Prasad Devarajan Journal: Clin J Am Soc Nephrol Date: 2008-03-12 Impact factor: 8.237
Authors: Michael Zappitelli; Pierre-Luc Bernier; Richard S Saczkowski; Christo I Tchervenkov; Ronald Gottesman; Adrian Dancea; Ayaz Hyder; Omar Alkandari Journal: Kidney Int Date: 2009-07-29 Impact factor: 10.612
Authors: K R Pedersen; J V Povlsen; S Christensen; J Pedersen; K Hjortholm; S H Larsen; V E Hjortdal Journal: Acta Anaesthesiol Scand Date: 2007-11 Impact factor: 2.105
Authors: Andrea Lassnigg; Daniel Schmidlin; Mohamed Mouhieddine; Lucas M Bachmann; Wilfred Druml; Peter Bauer; Michael Hiesmayr Journal: J Am Soc Nephrol Date: 2004-06 Impact factor: 10.121
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Tara M Neumayr; Jeff Gill; Julie C Fitzgerald; Avihu Z Gazit; Jose A Pineda; Robert A Berg; J Michael Dean; Frank W Moler; Allan Doctor Journal: Pediatr Crit Care Med Date: 2017-10 Impact factor: 3.624
Authors: Nicole S Wilder; Sunkyung Yu; Janet E Donohue; Caren S Goldberg; Neal B Blatt Journal: Pediatr Crit Care Med Date: 2016-05 Impact factor: 3.624